Cargando…
Pharos 2023: an integrated resource for the understudied human proteome
The Illuminating the Druggable Genome (IDG) project aims to improve our understanding of understudied proteins and our ability to study them in the context of disease biology by perturbing them with small molecules, biologics, or other therapeutic modalities. Two main products from the IDG effort ar...
Autores principales: | Kelleher, Keith J, Sheils, Timothy K, Mathias, Stephen L, Yang, Jeremy J, Metzger, Vincent T, Siramshetty, Vishal B, Nguyen, Dac-Trung, Jensen, Lars Juhl, Vidović, Dušica, Schürer, Stephan C, Holmes, Jayme, Sharma, Karlie R, Pillai, Ajay, Bologa, Cristian G, Edwards, Jeremy S, Mathé, Ewy A, Oprea, Tudor I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825581/ https://www.ncbi.nlm.nih.gov/pubmed/36624666 http://dx.doi.org/10.1093/nar/gkac1033 |
Ejemplares similares
-
TCRD and Pharos 2021: mining the human proteome for disease biology
por: Sheils, Timothy K, et al.
Publicado: (2020) -
Pharos: Collating protein information to shed light on the druggable genome
por: Nguyen, Dac-Trung, et al.
Publicado: (2017) -
Correction to ‘Pharos 2023: An integrated resource for the understudied human proteome’
Publicado: (2023) -
DrugCentral 2018: an update
por: Ursu, Oleg, et al.
Publicado: (2019) -
DrugCentral 2023 extends human clinical data and integrates veterinary drugs
por: Avram, Sorin, et al.
Publicado: (2022)